An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.

He died of Alzheimer’s in 2019, at the age of 66. “That’s old for our family,” Reiswig said. For years, Reiswig resisted finding out whether he carried the mutation, but he did get tested ...

New Study Links Lower Proportions of Certain Sleep Stages to Brain Changes Associated With Alzheimer's Disease Mar. 31, 2025 — New research reveals that lower proportions of specific sleep ...

Alzheimer’s is a devastating disease that afflicts roughly 6.7 million Americans, but scientists may have just found a way to reverse its effects by using a common herb found in many products ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...